Videos

Press Releases

Latest Newsletter

News

Filter on topic
  • ECCO 2019 European Cancer Summit

    News

    EORTC driving the policy agenda for clinical cancer research in Europe

  • E2-RADIate

    News,Radiation Oncology Group

    PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease

  • News

    EORTC at ISCB 40, Annual Conference of the International Society for Clinical Biostatistics

  • ASCO19 - Gemma-Kenter - study 55994 study

    Gynecological Cancer Group,News

    Defining the best treatment for locally advanced cervical cancer

  • ASCO19 - Patrick Schöffski - study 1317

    News,Soft Tissue and Bone Sarcoma Group

    Assessment of a potential new treatment option for patients with metastatic gastrointestinal stromal tumor (GIST) that may overcome resistance to established compounds

  • ASCO19 -Sylvie Bonvalot - STRASS study

    News,Soft Tissue and Bone Sarcoma Group

    Looking for answers in the search for the best treatment of retroperitoneal sarcoma

  • ASCO19 - 18071 study - Prof. Eggermont

    Melanoma Group,News

    Sustained long term survival benefit with adjuvant ipilimumab in patients with high risk stage III melanoma

  • ASCO19 - Bertrand Tombal - EORTC study 1333

    Genito-Urinary Cancers Group,News

    Preliminary results confirm that the addition of bone-protecting agents to Radium-233 (Ra-233) treatment can limit fractures in metastatic castration resistant prostate cancer patients

  • ASCO Annual Meeting 2019

    News

    EORTC abstracts selected at ASCO

  • Collaboration for Cancer Prevention, Research and Support

    News

    EORTC proudly joins Walgreens Boots Alliance in a Transatlantic Charitable Partnership that aims to meet the needs of people living with cancer